Imported drugs are out of stock due to COVID-19 crisis
By Kim, Min-Gun | translator Choi HeeYoung
20.04.07 12:35:00
가나다라
0
Production and export permits in the UK, Germany, and Belgium have been delayed, which has hampered domestic supply and demand
In Europe, companies other than essential facilities such as pharmacies and supermarkets have been suspended
According to the distribution industry on the 7th, domestic and foreign pharmaceutical companies, such as Kuhnil Pharmaceutical, Daewoong Pharmaceutical, JW Pharmaceutical, and Pfizer Korea, stopped supply due to delays in the production of some specialized pharmaceutical products.
Recently, Amilo (100T/1000T), a diuretic sold by Kuhnil, was temporarily out of stock. This is because the factory in China, the main raw material for the production of Amiloride, was caught in the aftermath of COVID-19.
Kuhnil announced that it will stop operating the plant by May 8th a
Kim, Min-Gun(kmg@dailypharm.com)
If you want to see the full article, please JOIN US (click)